Heller SR, Frier BM, Hersløv ML, Gundgaard J, Gough SCL. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med (Internet). 2016;33(4):471–7. https://doi.org/10.1111/dme.12844.

Article  CAS  Google Scholar 

Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract (Internet). 2009;63:6–10. https://doi.org/10.1111/j.1742-1241.2009.02176.x.

Article  CAS  Google Scholar 

Hortensius J, Kleefstra N, Houweling ST, van der Bijl JJ, Gans RO, Bilo HJ. What do professionals recommend regarding the frequency of self-monitoring of blood glucose? Neth J Med. 2012;70(6):287–91.

PubMed  CAS  Google Scholar 

Knapp S, Manroa P, Doshi K. Self-monitoring of blood glucose: advice for providers and patients. Cleve Clin J Med. 2016;83(5):355–60.

Article  PubMed  Google Scholar 

da Brasil MS. Protocolo Clínico e Diretrizes Terapêuticas do Diabete Melito Tipo 2; 2020.

Mogre V, Johnson NA, Tzelepis F, Shaw JE, Paul C. A systematic review of adherence to diabetes self-care behaviours: evidence from low- and middle-income countries. J Adv Nurs. 2019;75(12):3374–89.

Article  PubMed  Google Scholar 

Lamounier RNN, Geloneze B, Leite SOO, Montenegro R, Zajdenverg L, Fernandes M, et al. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil. Diabetol Metab Syndr (Internet). 2018;10(1):83. https://doi.org/10.1186/s13098-018-0379-5.

Article  CAS  Google Scholar 

FreeStyle Libre—Sistema Flash de Monitoramento de Glicose. Disponível em: <https://www.freestylelibre.com.br/index.html>. Acesso em 13 de maio de 2020. 2020.

Unger J, Kushner P, Anderson JE. Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care. Postgr Med. 2020;2020:1.

Google Scholar 

Stone JY, Bailey TS. Benefits and limitations of continuous glucose monitoring in type 1 diabetes. Expert Rev Endocrinol Metab. 2020;15(1):41–9.

Article  PubMed  CAS  Google Scholar 

Palylyk-Colwell E, Ford C. Flash glucose monitoring system for diabetes. CADTH Issues Emerg Health Technol. 2016;2016:1.

Google Scholar 

Mancini G, Berioli MG, Santi E, Rogari F, Toni G, Tascini G, et al. Flash glucose monitoring: a review of the literature with a special focus on type 1 diabetes. Nutrients. 2018;10(8):1.

Article  Google Scholar 

Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernandez R, Escalada FJ, et al. Clinical Approach to flash glucose monitoring: an expert recommendation. BMC Endocr Disord. 2020;14(1):155–64.

Google Scholar 

Leelarathna L, Wilmot EG. Flash forward: a review of flash glucose monitoring. Diabet Med. 2018;35(4):472–82.

Article  PubMed  CAS  Google Scholar 

Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, et al. Practical implementation, education and interpretation guidelines for continuous glucose monitoring: a French position statement. Diabetes Metab. 2018;44(1):61–72.

Article  PubMed  CAS  Google Scholar 

CADTH. Flash glucose monitoring system FreeStyle Libre to monitor glycemia in patients with diabetes; 2020. p. undefined-51.

Poole R. Diagnosis and management of type 1 diabetes in adults. Practitioner. 1861;2022(266):23–6.

Google Scholar 

NICE Guidelines. Recommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE. NICE Guidel. 2022(June):1–68.

Martyn A. Type 2 diabetes in adults. Nurs Stand. 2006;20(30):67.

Google Scholar 

Ministério da Saúde (Brasil). Secretaria de Ciência-Tecnologia e Insumos Estratégicos. Departamento de Ciência e Teccnologia. Diretrizes metodológicas: estudos de avaliação econômica de tecnologias em saúde. 2nd ed. Brasília: Ministério da Saúde; 2014. p. 132.

York Health Economics Consortium. Incremental Cost-Effectiveness Ratio (ICER). 2023; Available from: https://yhec.co.uk/glossary/incremental-cost-effectiveness-ratio-icer/.

Shafrin J, May S, Skornicki M, Hathway J, Macaulay R, Villeneuve J, et al. Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments. Value Heal [Internet]. 2016;19(7):A731. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1098301516335689.

Brasil. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas de Diabetes Melito Tipo 1. 2019; Available from: https://www.gov.br/conitec/pt-br/midias/protocolos/portaria-conjunta-pcdt-diabete-melito-1.pdf.

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254–63.

Article  PubMed  Google Scholar 

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-PP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther (Internet). 2017;8(1):55–73. https://doi.org/10.1007/s13300-016-0223-6.

Article  CAS  Google Scholar 

Hellmund R, Weitgasser R, Blissett D. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment. Diabetes Res Clin Pr. 2018;138:193–200.

Article  Google Scholar 

Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C. The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. Diabetes Technol Ther. 2019;21(1):1–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Roussel R, Guerci B, Vicaut E, Depouvourville G, Detournay B, Emery C, et al. 68-OR: dramatic drop in ketoacidosis rate after freestyle libre system initiation in type 1 and type 2 diabetes in france, especially in people with low self-monitoring of blood glucose (SMBG): a nationwide study. Diabetes. 2020;69(Supplement 1):68-OR.

Article  Google Scholar 

Bahia L, Kupfer R, Momesso D, Cabral DAP, Tschiedel B, Puñales M, et al. Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study. Diabetol Metab Syndr. 2017;9(1):9.

Article  PubMed  PubMed Central  Google Scholar 

Lauridsen JT, Lønborg J, Gundgaard J, Jensen HH. Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2014;23(9):2645–50.

Article  Google Scholar 

Matza LS, Stewart KD, Davies EW, Hellmund R, Polonsky WH, Kerr D. Health state utilities associated with glucose monitoring devices. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2017;20(3):507–11.

Article  Google Scholar 

Evans M, Khunti K, Mamdani M, Galbo-Jørgensen CB, Gundgaard J, Bøgelund M, et al. Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes. 2013;11:90.

Article  PubMed  PubMed Central  Google Scholar 

Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making. 2016;36(8):1020–33.

Article  PubMed  PubMed Central  Google Scholar 

Sociedade Brasileira de Diabetes (SBD). Diretrizes Sociedade Brasileira de Diabetes 2019–2020. Available on: <https://www.diabetes.org.br/profissionais/images/banners/Diretrizes_SBD_2020_04FEV20.pdf>. 1 Mar 2023; 2020.

Banco de Preços em Saúde. Código do CATMAT: BR0389555; Compras de 2022; 2023.

Banco de Preços em Saúde. Código do CATMAT: BR0339565; Compras de 2022; 2023.

Banco de Preços em Saúde. Código do CATMAT: BR0338605; Compras de 2022; 2023.

BRASIL.Ministério da Saúde. Departamento de Informática do Sistema Único de Saúde (DATASUS); 2022.

Oyagüez I, Merino-Torres JF, Brito M, Bellido V, Cardona-Hernandez R, Gomez-Peralta F, et al. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care (Internet). 2020;8(1):001330. https://doi.org/10.1136/bmjdrc-2020-001330.

Article  Google Scholar 

Lamounier R, Ermetice M, Griciunas F, Silva C. Costs of managing hypoglycaemias among insulin-treated patients with diabetes: results from the hat study in Brazil. Value Heal. 2017;20(9):PA920-A921.

Article  Google Scholar 

Gordon I, Rutherford C, Makarounas-Kirchmann K, Kirchmann M. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System. Diabetes Res Clin Pract (Internet). 2020 Jun;164:108158. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168822720304083.

Dicembrini I, Mannucci E, Monami M, Pala L. Impact of technology on glycaemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Obes Metab (Internet). 2019;21(12):2619–25. https://doi.org/10.1111/dom.13845.

Article  CAS  Google Scholar 

NICE. National Institute for Health and Care Excellence. Vol. Published:, NICE guideline. Type 1 diabetes in adults: diagnosis and management; 2022.

Brasil.Ministério da Saúde. O uso de limiared de custo-efetividade nas decisões em saúde: Recomendação da Comissão Nacional de Incorporação de Tecnologias no SUS (Internet); 2022. Available from: https://www.gov.br/conitec/pt-br/midias/pdf/2022/20221106_relatorio-uso-de-limiares-de-custo-efetividade-nas-decisoes-em-saude.pdf.

York Health Economics Consortium. Deterministic Sensitivity Analysis (Internet). 2023. Available from: https://yhec.co.uk/glossary/deterministic-sensitivity-analysis/#:~:text=Deterministic sensitivity analysis (DSA) is parameter or set of parameters.

Staneley H. Near Field Communication: What is NFC & How to Use It. Available from: https://www.shopify.com/retail/near-field-communication.